Mikhail S. Drenichev

Dr. Mikhail S. Drenichev

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Molecular Biology
Verified
Journal Article
Closed access
PDF file
AZA. A. Zenchenko
A. A. Zenchenko
MDMikhail S. Drenichev
Mikhail S. Drenichev
III. A. Il’ICheva
I. A. Il’ICheva
SMS. N. Mikhailov
S. N. Mikhailov
The emergence of new viruses and resistant strains of pathogenic microorganisms has become a powerful stimulus in the search for new drugs. Nucleosides are a promising class of natural compounds, and more than a hundred drugs have already been created based on them, including antiviral, antibacterial and antitumor agents. The review considers the structural and functional features and mechanisms of action of known nucleoside analogs with antiviral, antibacterial or antiprotozoal activity. Particular attention is paid to the mechanisms that determine the antiviral effect of nucleoside analogs containing hydrophobic fragments. Depending on the structure and position of the hydrophobic substituent, such nucleosides can either block the process of penetration of viruses into cells or inhibit the stage of genome replication. The mechanisms of inhibition of viral enzymes by compounds of nucleoside and non-nucleoside nature have been compared. The stages of creation of antiparasitic drugs, which are based on the peculiarities of metabolic transformations of nucleosides in humans body and parasites, have been considered. A new approach to the creation of drugs is described, based on the use of prodrugs of modified nucleosides, which, as a result of metabolic processes, are converted into an effective drug directly in the target organ or tissue. This strategy makes it possible to reduce the general toxicity of the drug to humans and to increase the effectiveness of its action on cells infected by the virus.

8 November 2017 in Advanced Synthesis & Catalysis
Verified
Journal Article
Closed access
PDF file
MDMikhail S. Drenichev
Mikhail S. Drenichev
CACyril S. Alexeev
Cyril S. Alexeev
NKNikolay N. Kurochkin
Nikolay N. Kurochkin
SMSergey N. Mikhailov
Sergey N. Mikhailov

1 January 2018 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
AKAnastasia O. Komarova
Anastasia O. Komarova
MDMikhail S. Drenichev
Mikhail S. Drenichev
NDNadezhda S. Dyrkheeva
Nadezhda S. Dyrkheeva
IKIrina V. Kulikova
Irina V. Kulikova
VOVladimir E. Oslovsky
Vladimir E. Oslovsky
Olga LavrikOlga Lavrik
Olga Lavrik
A new class of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors based on disaccharide nucleosides was identified. TDP1 plays an essential role in the resistance of cancer cells to currently used antitumour drugs based on Top1 inhibitors such as topotecan and irinotecan. The most effective inhibitors investigated in this study have IC50 values (half-maximal inhibitory concentration) in 0.4–18.5 µM range and demonstrate relatively low own cytotoxicity along with significant synergistic effect in combination with anti-cancer drug topotecan. Moreover, kinetic parameters of the enzymatic reaction and fluorescence anisotropy were measured using different types of DNA-biosensors to give a sufficient insight into the mechanism of inhibitor’s action.

20 July 2017 in Molecules
Verified
Journal Article
Open access
PDF file
VOVladimir Oslovsky
Vladimir Oslovsky
MDMikhail S. Drenichev
Mikhail S. Drenichev
LSLiang Sun
Liang Sun
NKNikolay N. Kurochkin
Nikolay N. Kurochkin
VKVladislav E. Kunetsky
Vladislav E. Kunetsky
SMSergey N. Mikhailov
Sergey N. Mikhailov
Recently, we demonstrated that the natural cytokinin nucleosides N6-isopentenyladenosine (iPR) and N6-benzyladenosine (BAPR) exert a potent and selective antiviral effect on the replication of human enterovirus 71. In order to further characterize the antiviral profile of this class of compounds, we generated a series of fluorinated derivatives of BAPR and evaluated their activity on the replication of human enterovirus 71 in a cytopathic effect (CPE) reduction assay. The monofluorination of the BAPR-phenyl group changed the selectivity index (SI) slightly because of the concomitant high cell toxicity. Interestingly, the incorporation of a second fluorine atom resulted in a dramatic improvement of selectivity. Moreover, N6-trifluoromethylbenzyladenosine derivatives (9–11) exhibited also a very interesting profile, with low cytotoxicity observed. In particular, the analogue N6-(3-trifluoromethylbenzyl)-adenosine (10) with a four-fold gain in potency as compared to BAPR and the best SI in the class represents a promising candidate for further development.

Verified
Journal Article
Open access
PDF file
ESEkaterina M Savelieva
Ekaterina M Savelieva
AZAnastasia Zenchenko
Anastasia Zenchenko
MDMikhail S. Drenichev
Mikhail S. Drenichev
AKAnna Artemovna Kozlova
Anna Artemovna Kozlova
NKNikolay N. Kurochkin
Nikolay N. Kurochkin
GRGeorgy A. Romanov
Georgy A. Romanov
Cytokinins, classical phytohormones, affect all stages of plant ontogenesis, but their application in agriculture is limited because of the lack of appropriate ligands, including those specific for individual cytokinin receptors. In this work, a series of chiral N6-benzyladenine derivatives were studied as potential cytokinins or anticytokinins. All compounds contained a methyl group at the α-carbon atom of the benzyl moiety, making them R- or S-enantiomers. Four pairs of chiral nucleobases and corresponding ribonucleosides containing various substituents at the C2 position of adenine heterocycle were synthesized. A nucleophilic substitution reaction by secondary optically active amines was used. A strong influence of the chirality of studied compounds on their interaction with individual cytokinin receptors of Arabidopsis thaliana was uncovered in in vivo and in vitro assays. The AHK2 and CRE1/AHK4 receptors were shown to have low affinity for the studied S-nucleobases while the AHK3 receptor exhibited significant affinity for most of them. Thereby, three synthetic AHK3-specific cytokinins were discovered: N6-((S)-α-methylbenzyl)adenine (S-MBA), 2-fluoro,N6-((S)-α-methylbenzyl)adenine (S-FMBA) and 2-chloro,N6-((S)-α-methylbenzyl)adenine (S-CMBA). Interaction patterns between individual receptors and specific enantiomers were rationalized by structure analysis and molecular docking. Two other S-enantiomers (N6-((S)-α-methylbenzyl)adenosine, 2-amino,N6-((S)-α-methylbenzyl)adenosine) were found to exhibit receptor-specific and chirality-dependent anticytokinin properties.

12 September 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
ABAdam M. Bayless
Adam M. Bayless
LSLijiang Song
Lijiang Song
MSMitchell Sorbello
Mitchell Sorbello
SOSam C. Ogden
Sam C. Ogden
TTTyler S. Todd
Tyler S. Todd
MNMarc T. Nishimura
Marc T. Nishimura
The TIR (Toll/interleukin-1 receptor) domain is an ancient protein module that functions in immune and cell death responses across the Tree of Life. TIR domains encoded by plants and prokaryotes function as enzymes to produce diverse small molecule immune signals. Plant genomes can encode hundreds of TIR-domain containing proteins—many of which confer important agricultural disease resistance as TIR-NLR (nucleotide-binding, leucine-rich repeat) immune receptors. Despite their importance, how natural variation influences TIR enzymatic output and immunity-associated cell death is largely unexplored. We assayed a complete collection of the TIR domains of Arabidopsis thaliana Col-0 (the “AtTIRome”) to explore variation in TIR metabolite production and cell death signaling. Roughly half of the AtTIRome triggered cell death in transient assays. Artificial TIR proteins designed based on consensus sequences of the AtTIRome’s cell death phenotypic classes revealed polymorphisms controlling variation in TIR cell death elicitation and metabolite production. Structure–function analyses of artificial TIRs revealed that natural variation in the “BB-loop”, a flexible region overlying the catalytic pocket, determines differences in function across Arabidopsis TIR-containing proteins. We further demonstrate that artificial TIRs are functional on an NLR chassis and that BB-loop variation can tune the activity of a natural TIR-NLR protein. These findings shed light on the diversity of TIR outputs and reveal methods to design and engineer TIR-based immune receptors.